title: Primary nasal tuberculosis-a rare clinical entity.
abstract: Primary tuberculosis of the nose is very rare. We report a case of a 35-year-old woman who presented with bilateral nasal obstruction and epistaxis of 3 months' duration but who was otherwise healthy. She was diagnosed with primary nasal septal tuberculosis and was treated with antituberculosis DOTS (directly observed treatment, short course) therapy for 6 months with complete recovery. Given the resurgence of tuberculosis in recent times, it is important that clinicians remain aware of this rare and treatable clinical entity.
authors.affiliation: Department of ENT, SKIMS Medical College, Srinagar, Jammu and Kashmir, India. lerra1jammu@gmail.com
authors.forename: Sandeep
authors.initials: S
authors.lastname: Lerra
authors.forename: Tanvir
authors.initials: T
authors.lastname: Nazir
authors.forename: Sajjad
authors.initials: S
authors.lastname: Mir Qadri
authors.forename: Masod
authors.initials: M
authors.lastname: Kirmani
mesh_terms: D000328:Adult; D000995:Antitubercular Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D004844:Epistaxis / Q000209:etiology; D005260:Female; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D015508:Nasal Obstruction / Q000209:etiology; D011718:Pyrazinamide / Q000627:therapeutic use; D012220:Rhinitis / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy*; D012293:Rifampin / Q000627:therapeutic use; D012852:Sinusitis / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy*; D014376:Tuberculosis / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy*
chemical_list: D000995:Antitubercular Agents; D011718:Pyrazinamide; D007538:Isoniazid; D012293:Rifampin